Description
Deucrava 6 mg is an oral medication containing Deucravacitinib, a selective Tyrosine Kinase 2 (TYK2) inhibitor. It is indicated for the treatment of moderate-to-severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy . Manufactured by Ziska Pharmaceuticals Ltd., Deucrava offers a novel mechanism of action, providing an effective and convenient treatment option for patients.
.webp)
Change Language